Ladenburg Thalmann

Sixth Street Prices Public Offering of $300.0 million 5.625% Unsecured Notes due 2030 For more info: https://lnkd.in/eG8wUTrQ

Intelligent Bio Solutions Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter’s Option to Purchase Additional Shares of Common Stock For more info: https://lnkd.in/eWDGwf8E

Ladenburg Acts as Sales Agent in $250 Million At-the-Market Offering for SoundHound AI

Ladenburg Thalmann Welcomes Samir Hussein as Managing Director in TMT Investment Banking New York, NY, January 28, 2025 — Ladenburg Thalmann is pleased to announce the appointment of Samir Hussein as Managing Director.?Based in New York, Samir has over twenty years of TMT investment banking experience advising management teams and boards of directors on capital raising and M&A transactions. Prior to joining Ladenburg, Samir was Co-Head of the Technology corporate finance practice at Duff & Phelps, a Managing Director in the TMT investment banking groups at Oppenheimer, JMP Securities and Deutsche Bank, and a Vice President at Morgan Stanley and Bank of America. Samir earned a Juris Doctor from New York University School of Law and a Bachelor of Science in Finance and a Bachelor of Arts in Psychology from Boston University. "Samir will be instrumental in shaping our technology sector strategy as his background and expertise fits perfectly with our client-first approach,” noted Nicholas Stergis, Head of Investment Banking at Ladenburg Thalmann.

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock For more info: https://lnkd.in/eDPhz3mQ

Palisade Bio Announces Closing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules For more info: https://lnkd.in/e38YxbDK

Thank You for Making the Oncology Innovators & Investors Symposium a Success! ? Ladenburg Thalmann would like to extend our sincere gratitude to all the attendees, presenting companies, and participants who joined us for the 2024 Virtual Oncology Innovators & Investors Symposium. ? Your engagement and insights helped make this event a tremendous success, showcasing groundbreaking advancements in oncology and fostering meaningful connections between innovators and investors. ? We look forward to continuing the conversation and supporting innovation in oncology. Thank you for being part of this important dialogue.

Autonomix Medical Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option For more info: https://lnkd.in/e5bwwhfM

Chesapeake Utilities Corporation Announces $100 Million At-The-Market Equity Offering Program For more info: https://lnkd.in/eBVrjKyC